Filing Details

Accession Number:
0001493152-24-047261
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-21 21:53:44
Reporting Period:
2024-11-20
Accepted Time:
2024-11-21 21:53:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1962011 Kairos Pharma Ltd. KAPA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550545 S John Yu C/O Kairos Pharma, Ltd.
2355 Westwood Blvd, #139
Los Angeles CA 90064
Ceo And Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-20 4,000 $1.44 5,341,837 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct